↓ Skip to main content

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
113 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd007891.pub3
Pubmed ID
Authors

Emma J Welsh, Christopher J Cates, Phillippa Poole

Abstract

Combination therapy (inhaled corticosteroids and long-acting beta2-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD). There is uncertainty about the relative benefits and harms of these treatments.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 3%
United States 1 <1%
Germany 1 <1%
Unknown 108 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 15%
Researcher 16 14%
Student > Master 15 13%
Other 11 10%
Professor 9 8%
Other 30 27%
Unknown 15 13%
Readers by discipline Count As %
Medicine and Dentistry 66 58%
Nursing and Health Professions 8 7%
Social Sciences 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 11 10%
Unknown 18 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2014.
All research outputs
#10,024,012
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#8,520
of 8,923 outputs
Outputs of similar age
#128,586
of 192,470 outputs
Outputs of similar age from Cochrane database of systematic reviews
#189
of 202 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,470 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 202 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.